Influenza A/H1N1 MF59-adjuvanted vaccine in preterm and term children aged 6 to 23 months

Pediatrics

Volumn 127, Issue 5, 2011, Pages

  Esposito, Susanna ^a   Pugni, Lorenza ^a   Daleno, Cristina ^a   Ronchi, Andrea ^a   Valzano, Antonia ^a   Serra, Domenico ^a   Mosca, Fabio ^a   Principi, Nicola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

A H1N1 influenza vaccine; Adjuvants; MF59; Pandemic influenza; Preterm infants

Indexed keywords

ADJUVANT; INFLUENZA VACCINE; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG SAFETY; DRUG TOLERABILITY; EATING HABIT; FEMALE; FEVER; GESTATIONAL AGE; HUMAN; IMMUNOGENICITY; INFANT; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; PREMATURITY; PRIORITY JOURNAL; RHINITIS; SEROCONVERSION; SIDE EFFECT; SOMNOLENCE; VOMITING;

ADJUVANTS, IMMUNOLOGIC; FEMALE; HUMANS; IMMUNITY; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; ITALY; MALE; PANDEMICS; POLYSORBATES; PROSPECTIVE STUDIES; RISK ASSESSMENT; SQUALENE; STATISTICS, NONPARAMETRIC; TERM BIRTH; VACCINATION;

EID: 79955491362     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2010-1920     Document Type: Article

References (37)

1. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978 -1981. Am Rev Resp Dis. 1987;136(3): 550-555
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF Jr, Griffin MR. Effect of influenza on hospitalizations, outpatient visits, and course of antibiotics in children. N Engl J Med. 2000; 342(4):225-231 (Pubitemid 30058953)
3. Izurieta HS, Thompson WW, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med. 2000;342(4): 232-239 (Pubitemid 30058954)
4. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med. 2006; 355(1):31-40
5. Fiore AE, Shay DK, Broder K, et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Recomm Rep. 2009; 58(RR-8):1-52
6. Jefferson T, Rivetti A, Harnden A, Di Pietrantonj C, Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev. 2008;(2):CD004879
7. Groothuis JR, Levin MJ, Rabalais GP, Meiklejohn G, Lauer BA. Immunization of high-risk infants younger than 18 months of age with split-product influenza vaccine. Pediatrics. 1991;87(6):823-828
8. Hilleman MR. Serologic responses to split and whole swine influenza virus vaccines in light of the next influenza pandemic. J Infect Dis. 1977;136(suppl):S683-S685 (Pubitemid 8286948)
9. Parkman PD, Hopps HE, Rastogi SC, Meyer HM Jr. Summary of clinical trials of influenza virus vaccine in adults. J Infect Dis. 1977;136(suppl):S722-S730 (Pubitemid 8286955)
10. Kumagai T, Nagai K, Okui T, et al. Poor immune responses to influenza vaccination in infants. Vaccine. 2004;22(25-26): 3404-3410 (Pubitemid 39078758)
11. Groothuis JR, Levin MJ, Lehr MV, Weston JA, Hayward AR. Immune response to splitproduct influenza vaccine in preterm and full-term infants. Vaccine. 1992;10(4): 221-225
12. Vesikari T, Pellegrini M, Karvonen A, et al. Enhanced immunogenicity of seasonal in- fluenza vaccines in young children using MF59 adjuvant. Pediatr Infect Dis J. 2009; 28(7):563-571
13. Hahné S, Donker T, Meijer A, et al. Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. Euro Surveill. 2009;14(27):pii 19267
14. European Centre for Disease Prevention and Control. On the use of specific pandemic influenza vaccines. Available at: www.ecdc.europa. eu/en/healthtopics/Documents/0908- Influenza-AH1N1-On-the-use-of-specific- pandemic-influenza-vaccines.pdf. Accessed March 10, 2011
15. Centers for Disease Control and Prevention. People at high risk of developing flu-related complications. Available at: www.cdc.gov/ h1n1flu/highrisk.htm. Accessed March 10, 2011
16. Kelly H, Barr I. Large trials confirm immunogenicity of H1N1 vaccines. Lancet. 2010; 375(9708):6-9
17. Nolan T, McVernon J, Skeljo M, et al. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA. 2010;303(1):73
18. Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009;361(25): 2414-2423
19. Liang XF, Wang HQ, Wang JZ, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebocontrolled trial. Lancet. 2010;375(9708): 56-66
20. Esposito S, Molteni CG, Colombo C, et al. Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection. J Clin Virol. 2010;48(1):62-65
21. Esposito S, Molteni CG, Daleno C, et al. Collection by trained pediatricians or parents of mid-turbinate nasal flocked swabs for the detection of influenza viruses in childhood. Virol J. 2010;7:85
22. Esposito S, Molteni CG, Daleno C, et al. Clinical importance and impact on the households of oseltamivir-resistant seasonal A/H1N1 influenza virus in healthy children in Italy. Virol J. 2010;7:202
23. Menegon T, Baldo V, Bonello C, et al. Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population. Eur J Epidemiol. 1999; 15(6):573-576 (Pubitemid 29400033)
24. World Health Organization. WHO manual on animal influenza diagnosis and surveillance. Available at: www.who.int/csr/ resources/publications/influenza/ whocdscsrncs20025rev.pdf. Accessed March 2, 2011
25. European Agency for the Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products. Note for Guidance on Harmonisation of Requirements for In- fluenza Vaccines. London, United Kingdom: European Commission Enterprise and Industry DG; 1997. CPMP/BWP/214/96
26. Esposito S, Marchisio P, Ansaldi F, et al. A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6 -35 months. Vaccine. 2010;28(38): 6137-6144
27. Esposito S, Agliardi T, Giammanco A, et al. Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection. Infect Immun. 2001;69(7): 4516-4520 (Pubitemid 32574452)
28. Esposito S, Faldella G, Giammanco A, et al. Long-term pertussis-specific immune responses to a combined diphtheria, tetanus, tricomponent acellular pertussis and hepatitis B vaccine in pre-term infants. Vaccine. 2002;20(23-24):2928-2932 (Pubitemid 34785963)
29. Esposito S, Serra D, Gualtieri L, Cesati L, Principi N. Vaccines and preterm neonates: why, when, and with what. Early Hum Dev. 2009;85(10 suppl):S43-S45
30. Al-Khayatt R, Jennings R, Potter CW. Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond). 1984;93(2):301-312 (Pubitemid 15207959)
31. Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutinationinhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond). 1972;70(4):767-777
32. Esposito S, Marchisio P, Principi N. The global state of influenza in children. Pediatr Infect Dis J. 2008;27(11 suppl): S149-S153
33. Esposito S, Principi N. The rational use of influenza vaccines in healthy children and children with underlying conditions. Curr Opin Infect Dis. 2009;22(3):244-249
34. Rizzo C, Rota MC, Bella A, et al. Crossreactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period. Vaccine. 2010;28(20):3558-3562
35. Hancock K, Veguilla V, Lu X, et al. Crossreactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361(20):1945-1952
36. Esposito S, Tremolati E, Bellasio M, et al. Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children. Vaccine. 2007;25(29):5283-5289 (Pubitemid 46992760)
37. Nelson JC, Bittner RC, Bounds L, et al. Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study. Am J Public Health. 2009; 99(suppl 2):S389-S397